RECRUITING

Maternal Fetal Device Performance Twins

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Maternal Fetal Monitoring devices assist the health care professional in acquiring, monitoring, and storing fetal and maternal physiologic data which support clinical decision making for pregnant women and assesses the overall fetal health status during pregnancy and delivery. This study aims to support a new maternal fetal monitoring device with clinical data by collecting simultaneous, continuous, external, distinguishable FHRs from twin pregnancies using ultrasound Doppler transducers from the new maternal fetal monitoring investigational device and a marketed ultrasound imaging device.

Official Title

Maternal Fetal Device Performance Testing During Antepartum Twin Monitoring

Quick Facts

Study Start:2025-01-21
Study Completion:2025-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06835647

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Able and willing to provide written informed consent.
  2. 2. Twin pregnancy.
  3. 3. Aged 18+.
  4. 4. Greater than or equal to 30 0/7 weeks gestation.
  5. 5. Patient has none of the exclusion criteria.
  1. 1. Non-twin pregnancy.
  2. 2. Involvement in another clinical trial currently or previously in this pregnancy that, in the investigator's opinion, would affect the conduct of this study.
  3. 3. Medical or obstetric problem that in investigator's opinion would make the patient incapable of taking part in the study.
  4. 4. Inability to understand the consent information due to medical illness, diminished intellectual capacity, or insurmountable language barrier.

Contacts and Locations

Study Contact

Amie Research Program Integrator
CONTACT
816-719-6765
Amie.Robinson@gehealthcare.com

Principal Investigator

Monica Rabanal, NP
PRINCIPAL_INVESTIGATOR
Element Materials Technology

Study Locations (Sites)

Element Materials Technology
Louisville, Colorado, 80027
United States

Collaborators and Investigators

Sponsor: GE Healthcare

  • Monica Rabanal, NP, PRINCIPAL_INVESTIGATOR, Element Materials Technology

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-01-21
Study Completion Date2025-12-31

Study Record Updates

Study Start Date2025-01-21
Study Completion Date2025-12-31

Terms related to this study

Keywords Provided by Researchers

  • Pregnancy
  • Twins

Additional Relevant MeSH Terms

  • Pregnancy